Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials

Background: Antihypertensive treatment may have different effects on central arterial hemodynamics. The extent of the difference in effects between various antihypertensive drugs remains undefined.Methods: We conducted a systematic review and meta-analysis of randomized controlled trials that explor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yi-Bang Cheng, Jia-Hui Xia, Yan Li, Ji-Guang Wang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/adade729c17842929a5b2bf57e3432a4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:adade729c17842929a5b2bf57e3432a4
record_format dspace
spelling oai:doaj.org-article:adade729c17842929a5b2bf57e3432a42021-11-30T18:30:31ZAntihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials1664-042X10.3389/fphys.2021.762586https://doaj.org/article/adade729c17842929a5b2bf57e3432a42021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphys.2021.762586/fullhttps://doaj.org/toc/1664-042XBackground: Antihypertensive treatment may have different effects on central arterial hemodynamics. The extent of the difference in effects between various antihypertensive drugs remains undefined.Methods: We conducted a systematic review and meta-analysis of randomized controlled trials that explored the effects of antihypertensive agents on both central and peripheral systolic blood pressure (SBP) and pulse pressure (PP) or central augmentation index, with a special focus on the comparison between newer [renin-angiotensin-aldosterone system (RAS) inhibitors and calcium-channel blockers (CCBs)] and older antihypertensive agents (diuretics and β- and α-blockers).Results: In total, 20 studies (n = 2,498) were included. Compared with diuretics (10 studies), β-blockers (16 studies), or an α-blocker (1 study), RAS inhibitors (21 studies), and CCBs (6 studies) more efficaciously (P < 0.001) reduced both central and peripheral SBP by a weighted mean difference of −5.63 (−6.50 to −4.76 mmHg) and −1.97 mmHg (−2.99 to −0.95 mmHg), respectively. Compared with older agents, the newer agents also more efficaciously (P < 0.001) reduced central PP (−3.27 mmHg; −4.95 to −1.59 mmHg), augmentation index (−6.11%; −7.94 to −4.29) and augmentation (−3.35 mmHg; −5.28 to –1.42 mmHg) but not peripheral PP (p ≥ 0.09). Accordingly, the newer agents reduced central-to-peripheral PP amplification significantly less than the older agents (0.11 mmHg; 0.05 to 0.17 mmHg; P < 0.001).Conclusion: Newer agents, such as RAS inhibitors and CCBs, were significantly more efficacious than older agents in their effects on central hemodynamics.Yi-Bang ChengJia-Hui XiaYan LiJi-Guang WangFrontiers Media S.A.articleantihypertensive treatmentcentral blood pressureaugmentation indexrandomized controlled trialdrugPhysiologyQP1-981ENFrontiers in Physiology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic antihypertensive treatment
central blood pressure
augmentation index
randomized controlled trial
drug
Physiology
QP1-981
spellingShingle antihypertensive treatment
central blood pressure
augmentation index
randomized controlled trial
drug
Physiology
QP1-981
Yi-Bang Cheng
Jia-Hui Xia
Yan Li
Ji-Guang Wang
Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials
description Background: Antihypertensive treatment may have different effects on central arterial hemodynamics. The extent of the difference in effects between various antihypertensive drugs remains undefined.Methods: We conducted a systematic review and meta-analysis of randomized controlled trials that explored the effects of antihypertensive agents on both central and peripheral systolic blood pressure (SBP) and pulse pressure (PP) or central augmentation index, with a special focus on the comparison between newer [renin-angiotensin-aldosterone system (RAS) inhibitors and calcium-channel blockers (CCBs)] and older antihypertensive agents (diuretics and β- and α-blockers).Results: In total, 20 studies (n = 2,498) were included. Compared with diuretics (10 studies), β-blockers (16 studies), or an α-blocker (1 study), RAS inhibitors (21 studies), and CCBs (6 studies) more efficaciously (P < 0.001) reduced both central and peripheral SBP by a weighted mean difference of −5.63 (−6.50 to −4.76 mmHg) and −1.97 mmHg (−2.99 to −0.95 mmHg), respectively. Compared with older agents, the newer agents also more efficaciously (P < 0.001) reduced central PP (−3.27 mmHg; −4.95 to −1.59 mmHg), augmentation index (−6.11%; −7.94 to −4.29) and augmentation (−3.35 mmHg; −5.28 to –1.42 mmHg) but not peripheral PP (p ≥ 0.09). Accordingly, the newer agents reduced central-to-peripheral PP amplification significantly less than the older agents (0.11 mmHg; 0.05 to 0.17 mmHg; P < 0.001).Conclusion: Newer agents, such as RAS inhibitors and CCBs, were significantly more efficacious than older agents in their effects on central hemodynamics.
format article
author Yi-Bang Cheng
Jia-Hui Xia
Yan Li
Ji-Guang Wang
author_facet Yi-Bang Cheng
Jia-Hui Xia
Yan Li
Ji-Guang Wang
author_sort Yi-Bang Cheng
title Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials
title_short Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials
title_full Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials
title_fullStr Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials
title_full_unstemmed Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials
title_sort antihypertensive treatment and central arterial hemodynamics: a meta-analysis of randomized controlled trials
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/adade729c17842929a5b2bf57e3432a4
work_keys_str_mv AT yibangcheng antihypertensivetreatmentandcentralarterialhemodynamicsametaanalysisofrandomizedcontrolledtrials
AT jiahuixia antihypertensivetreatmentandcentralarterialhemodynamicsametaanalysisofrandomizedcontrolledtrials
AT yanli antihypertensivetreatmentandcentralarterialhemodynamicsametaanalysisofrandomizedcontrolledtrials
AT jiguangwang antihypertensivetreatmentandcentralarterialhemodynamicsametaanalysisofrandomizedcontrolledtrials
_version_ 1718406401637744640